Skip to main content
An official website of the United States government

Pre-Cancer Atlas (PCA)

A tumor (yellow) is shown in the background. Components within the microenvironment are overlaid on the tumor, including a dendritic cell (pink), a T-cell (blue), a fibroblast (purple and pink), a natural killer cell (dark blue), a regulatory t cell (aqua), blood vessels (red), a macrophage cell (red with a yellow center), and a myeloid cell (green).

The Pre-cancer Atlas (PCA) Research Centers are part of the Human Tumor Atlas Network (HTAN). HTAN, an NCI-collaborative program, is constructing multi-dimensional atlases of the cellular, morphological, molecular, and spatial features of human cancers and their surrounding microenvironments over time.

The atlases being created by HTAN describe important changes during cancer progression, such as the transition of precancers to malignant tumors, the evolution of metastatic cancer, and the development of treatment resistance.

HTAN is supported by the NCI Division of Cancer Prevention (DCP), NCI Division of Biology (DCB), the NCI Division of Cancer Treatment and Diagnosis (DCTD), and the NCI Center for Strategic Science Initiatives (CSSI).

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

About Pre-Cancer Atlas

The Pre-cancer Atlas (PCA) Research Centers, along with the Human Tumor Atlas (HTA) Research Centers and a Data Coordinating Center (DCC), make up HTAN. Each PCA Research Center will create a 2D/3D precancer atlas of a pre-cancerous lesion, focusing on how it changes into cancer.

PCA Research Centers have three major tasks:

  • Collecting, processing, and labeling biospecimens.
  • Studying the molecular, cellular, and spatial details of the lesions.
  • Analyzing and modeling the data.

PCA Research Centers will collaborate with other components of HTAN to make the data and analytical tools available to the research community.

Grantee Details

PI Name Sort descending PI Organization Title Grant Number Program Official
Warner, Erica T

Massachusetts General Hospital
United States

Aspirins legacy on cancer and overall benefit: risk balance over a 15-year horizon 3U01CA301988-02S1 Asad Umar, D.V.M., Ph.D.
Washington, Karla

Washington University
United States

Problem-Solving Therapy for Cancer Caregivers: A Randomized Clinical Trial in Outpatient Palliative Care 5R01CA258311-05 Brennan Streck, Ph.D., RN, M.P.H.
Washington, Karla

Washington University
United States

Problem-Solving Therapy for Cancer Caregivers: A Randomized Clinical Trial in Outpatient Palliative Care 5R01CA258311-05 Brennan Streck, Ph.D., RN, M.P.H.
Watt, Gordon Patrick

Netherlands Cancer Institute
United States

Quantitative background parenchymal enhancement, measured on contrast-enhanced mammogram, as a novel marker of breast cancer risk 3R37CA284134-03S1 Claire Zhu, Ph.D.
Webster, Nicholas J

Veterans Medical Research Fdn/San Diego
United States

The Effect of Time-Restricted Eating on the Efficiency of Chemo- and Hormonal-Therapy in Breast Cancer 5R21CA288777-02 Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Webster, Nicholas J

University Of California, San Diego
United States

Time-restricted feeding and breast cancer 5R01CA196853-09 Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Wei, Lei

Roswell Park Cancer Institute Corp
United States

Advancing skin cancer prevention by tackling UV-induced clonogenic mutations 5R01CA255242-05 Wendy Wang, Ph.D., M.Sc.
Welsh, Joellen

State University Of New York At Albany
United States

Vitamin K: Body Pools and Function in Breast Cancer 5R01CA258231-05 Young Kim, Ph.D.
Whitman, Eric

Atlantic Health System, Inc.
United States

The Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC Corp) 3UG1CA239772-06S1 Vanessa A. White, M.P.H.
Whitman, Eric

Atlantic Health System, Inc.
United States

The Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC Corp) 3UG1CA239772-06S1 Vanessa A. White, M.P.H.
Wildman-Tobriner, Benjamin

Duke University
United States

AI for Differentiation of Low vs High Risk Thyroid Nodules on Ultrasound 1R01CA297227-01A1 Wendy Wang, Ph.D., M.Sc.
Wilkin, Timothy J.

University Of California, San Diego
United States

Partnership for advancing cervical cancer prevention in women living with HIV (CASCADE - Research Hub) 5UG1CA275414-05 Maria Silvina Frech, Ph.D., M.S.
Williams, Paige L

Harvard University D/B/A Harvard School Of Public Health
United States

Pediatric HIV/AIDS Cohort Study (PHACS) 2020 3P01HD103133-05S1 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Wilson, Michael R

Wayne State University
United States

Does obesity influence protein quality control in endometrial cancer? 5R00CA252152-05 Amit Kumar, Ph.D.
Winer, Rachel L.

University Of Washington
United States

The CASCADE CLIMB: Cervical cancer prevention in women Living with HIV research Mobilization Base 5UG1CA275402-04 Maria Silvina Frech, Ph.D., M.S.